The report details SD Biosensor's commitment to ESG management and their strategies for 2022-2023. Key highlights include the declaration of their ESG management vision, the completion of their Jeungpyeong factory construction, the development of the STANDARD M10 platform, and the acquisition of Meridian Bioscience, a US IVD company. SD Biosensor also emphasizes their social contributions through the ""Sustainable Diagnosis for Better Future"" project, which aims to establish production capacity for HIV self-test kits in Africa.
Issuing Company SD Bio Sensor Inc.
Report Type Sustainability Report
Report Language EN
Report Filesize 18.79 MB
No. of Pages 43 pages
Reporting periodJanuary 1, 2022-December 31, 2023
Report Edition1
Assurance Provider Unknown
Reporting Standards GRI 2021; ISO 26000; UNGC; others
Materiality Assessmenttrue
